(Allergan plc)

	AGN latest price $305.9569 (-0.24%) ($302.0480 - $307.9452) on Tue. Jul. 21, 2015.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.32% (three month average)
RSI	67
Latest Price	$305.9569(-0.24%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.3% a day on average for past five trading days.
Weekly Trend	AGN advances 1.9% a week on average for past two weeks.
Market Behavior	Value stocks sell-off for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(54%)    IBB(53%)    XBI(47%)    SPY(42%)    IVE(41%)
Factors Impacting AGN price	AGN will decline at least -0.66% in a week (0% probabilities).   VIXM(-31%)    TLT(-18%)    UUP(-6%)    SHY(-6%)    IGOV(-4%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.66% (StdDev 1.32%)
Hourly BBV	0 ()
Intraday Trend	-0.2%

5 Day Moving Average	$306.62(-0.22%)
10 Day Moving Average	$303.72(0.74%)
20 Day Moving Average	$300.01(1.98%)
To recent high	-1.3%
To recent low	12.1%
Market Cap	$100.874b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed